Oruka Therapeutics, Inc. · NASDAQ:ORKA
BlackRock, Inc.'s stake in Oruka Therapeutics, Inc. fell to 4.50% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 17, 2025
BlackRock, Inc.'s stake in Oruka Therapeutics, Inc. fell to 4.50%, 2,197,517 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G/A).
- Stake
- 4.50%
- Shares
- 2,197,517
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.50% | 2,197,517 |
Source
Related
- Oruka Therapeutics, Inc.
- BlackRock, Inc.
- Oruka Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G · BlackRock, Inc. · Jul 17, 2025
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026